The first Pfizer trade was made in Q1 1999.
Since then Donald Yacktman bought shares 23 more times and sold shares on 22 occasions. The investor completely sold their stake between Q4 2011 and Q4 2013.
Avg closing price
Price range
Sold -41.7 Thousand shares
Q4 2013
Avg closing price
$30.68
Price range
$28.24
-
$32.20
Sold 99.7% shares (-16.2 Million shares)
Q2 2013
Avg closing price
$29.12
Price range
$27.23
-
$31.08
Sold 2.8% shares (-467 Thousand shares)
Q1 2013
Avg closing price
$27.35
Price range
$25.85
-
$28.86
Sold 4.8% shares (-844 Thousand shares)
Q4 2012
Avg closing price
$25.02
Price range
$23.66
-
$26.04
Sold 0.2% shares (-27 Thousand shares)
Q3 2012
Avg closing price
$23.79
Price range
$22.34
-
$24.96
Sold 0.1% shares (-20.3 Thousand shares)
Q2 2012
Avg closing price
$22.39
Price range
$21.60
-
$23.08
Sold 3.2% shares (-577 Thousand shares)
Q1 2012
Avg closing price
$21.60
Price range
$20.95
-
$22.64
Sold 2.3% shares (-434 Thousand shares)
Q4 2011
Avg closing price
$19.74
Price range
$17.33
-
$21.83
Increased shares by 3.6% (+645 Thousand shares)
Q3 2011
Avg closing price
$18.68
Price range
$16.66
-
$20.78
Increased shares by 2.8% (+483 Thousand shares)
Q2 2011
Avg closing price
$20.58
Price range
$19.79
-
$21.45
Sold 0.1% shares (-16.5 Thousand shares)
Q1 2011
Avg closing price
$19.09
Price range
$17.68
-
$20.38
Increased shares by 5.0% (+831 Thousand shares)
Q4 2010
Avg closing price
$17.17
Price range
$16.30
-
$17.80
Increased shares by 3.3% (+530 Thousand shares)
Q3 2010
Avg closing price
$15.94
Price range
$14.14
-
$17.42
Increased shares by 62.8% (+6.22 Million shares)
Q2 2010
Avg closing price
$15.96
Price range
$14.26
-
$17.29
Increased shares by 32.4% (+2.42 Million shares)
Q1 2010
Avg closing price
$18.07
Price range
$16.91
-
$20.00
Increased shares by 14.6% (+952 Thousand shares)
Q4 2009
Avg closing price
$17.77
Price range
$16.15
-
$18.85
Increased shares by 55.8% (+2.34 Million shares)
Q3 2009
Avg closing price
$15.93
Price range
$14.20
-
$16.86
Increased shares by 393.6% (+3.35 Million shares)
Q2 2009